K201148 is an FDA 510(k) clearance for the EnSite Precision Cardiac Mapping System v2.6, EnSite Precision Software Installation v2.6, EnSite LiveView Dynamic Display Software License. This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).
Submitted by Abbott Medical (St. Paul, US). The FDA issued a Cleared decision on June 26, 2020, 58 days after receiving the submission on April 29, 2020.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.